| Serial Number | 88730797 |
| Word Mark | NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES |
| Filing Date | Tuesday, December 17, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, April 7, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | NUCLEAR DELIVERED ANTI BODY DRUG CONJUGATES |
| Goods and Services | Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 20, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, January 10, 2020 |
| First Use In Commerce Date | Friday, January 10, 2020 |
| Party Name | Angiex, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Thursday, April 7, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, April 7, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, September 3, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, September 3, 2021 | FINAL REFUSAL E-MAILED |
| Friday, September 3, 2021 | FINAL REFUSAL WRITTEN |
| Monday, August 16, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 9, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 10, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 10, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 10, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, January 25, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 25, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 22, 2021 | ASSIGNED TO LIE |
| Monday, October 12, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 14, 2020 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Monday, April 13, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 13, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, April 13, 2020 | NON-FINAL ACTION WRITTEN |
| Sunday, April 12, 2020 | USE AMENDMENT ACCEPTED |
| Thursday, April 2, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 1, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 1, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 2, 2020 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, April 2, 2020 | USE AMENDMENT FILED |
| Wednesday, April 1, 2020 | TEAS AMENDMENT OF USE RECEIVED |
| Tuesday, March 17, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 17, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 17, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, March 16, 2020 | ASSIGNED TO EXAMINER |
| Friday, December 20, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 20, 2019 | NEW APPLICATION ENTERED |